174 related articles for article (PubMed ID: 36378997)
1. A comprehensive review on the antidiabetic attributes of thiazolidine-4-ones: Synthetic strategies and structure-activity relationships.
Pradhan T; Gupta O; Kumar V; Sristi ; Chawla G
Arch Pharm (Weinheim); 2023 Feb; 356(2):e2200452. PubMed ID: 36378997
[TBL] [Abstract][Full Text] [Related]
2. Discovery of thiazolidine-2,4-dione/biphenylcarbonitrile hybrid as dual PPAR α/γ modulator with antidiabetic effect: in vitro, in silico and in vivo approaches.
Hidalgo-Figueroa S; Ramírez-Espinosa JJ; Estrada-Soto S; Almanza-Pérez JC; Román-Ramos R; Alarcón-Aguilar FJ; Hernández-Rosado JV; Moreno-Díaz H; Díaz-Coutiño D; Navarrete-Vázquez G
Chem Biol Drug Des; 2013 Apr; 81(4):474-83. PubMed ID: 23289972
[TBL] [Abstract][Full Text] [Related]
3. Thiazolidine-2,4-diones: progress towards multifarious applications.
Jain VS; Vora DK; Ramaa CS
Bioorg Med Chem; 2013 Apr; 21(7):1599-620. PubMed ID: 23419324
[TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity relationship analysis of thiazolidineones: potent antidiabetic compounds.
Vishvakarma VK; Singh P; Dubey M; Kumari K; Chandra R; Pandey ND
Drug Metabol Drug Interact; 2013; 28(1):31-47. PubMed ID: 23417104
[TBL] [Abstract][Full Text] [Related]
5. Synthetic Strategies of Thiazolidine-2,4-dione Derivatives for the Development of New Anti-diabetic Agents: Compressive Review.
Ray PK; Shabana K; Salahuddin ; Kumar R
Curr Top Med Chem; 2024; 24(10):885-928. PubMed ID: 38500288
[TBL] [Abstract][Full Text] [Related]
6. The medicinal perspective of 2,4-thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review.
Kajal K; Singh G; Pradhan T; Bhurta D; Monga V
Arch Pharm (Weinheim); 2022 Sep; 355(9):e2100517. PubMed ID: 35715383
[TBL] [Abstract][Full Text] [Related]
7. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition.
Gummidi L; Kerru N; Ebenezer O; Awolade P; Sanni O; Islam MS; Singh P
Bioorg Chem; 2021 Oct; 115():105210. PubMed ID: 34332231
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of thiazolidine-2,4-dione-pyrazole conjugates as antidiabetic, anti-inflammatory and antioxidant agents.
Bansal G; Singh S; Monga V; Thanikachalam PV; Chawla P
Bioorg Chem; 2019 Nov; 92():103271. PubMed ID: 31536952
[TBL] [Abstract][Full Text] [Related]
9. Thiazolidin-4-one-based derivatives - Efficient tools for designing antiprotozoal agents. A review of the last decade.
Tuszewska H; Szczepański J; Mandziuk S; Trotsko N
Bioorg Chem; 2023 Apr; 133():106398. PubMed ID: 36739686
[TBL] [Abstract][Full Text] [Related]
10. The Bioactivity of Thiazolidin-4-Ones: A Short Review of the Most Recent Studies.
Mech D; Kurowska A; Trotsko N
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768964
[TBL] [Abstract][Full Text] [Related]
11. Integrated fragment-based drug design and virtual screening techniques for exploring the antidiabetic potential of thiazolidine-2,4-diones: Design, synthesis and in vivo studies.
Gupta S; Baweja GS; Singh S; Irani M; Singh R; Asati V
Eur J Med Chem; 2023 Dec; 261():115826. PubMed ID: 37793328
[TBL] [Abstract][Full Text] [Related]
12. A convenient approach to synthesize substituted 5-Arylidene-3-m-tolyl thiazolidine-2, 4-diones by using morpholine as a catalyst and its theoretical study.
Jahan K; Khan KR; Akhter K; Romman UKR; Halim E
PLoS One; 2021; 16(3):e0247619. PubMed ID: 33661961
[TBL] [Abstract][Full Text] [Related]
13. SAR and lead optimization of (Z)-5-(4-hydroxy-3-methoxybenzylidene)-3-(2-morpholinoacetyl)thiazolidine-2,4-dione as a potential multi-target antidiabetic agent.
Shah M; Jan MS; Sadiq A; Khan S; Rashid U
Eur J Med Chem; 2023 Oct; 258():115591. PubMed ID: 37393789
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic journey of 2,4-thiazolidinediones as a versatile scaffold: An insight into structure activity relationship.
Naim MJ; Alam MJ; Ahmad S; Nawaz F; Shrivastava N; Sahu M; Alam O
Eur J Med Chem; 2017 Mar; 129():218-250. PubMed ID: 28231521
[TBL] [Abstract][Full Text] [Related]
15. Thiazolidinediones: An In-Depth Study of Their Synthesis and Application to Medicinal Chemistry in the Treatment of Diabetes Mellitus.
Long N; Le Gresley A; Wren SP
ChemMedChem; 2021 Jun; 16(11):1716-1735. PubMed ID: 33844475
[TBL] [Abstract][Full Text] [Related]
16. An overview on medicinal perspective of thiazolidine-2,4-dione: A remarkable scaffold in the treatment of type 2 diabetes.
Bansal G; Thanikachalam PV; Maurya RK; Chawla P; Ramamurthy S
J Adv Res; 2020 May; 23():163-205. PubMed ID: 32154036
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, in vitro, in silico and in vivo hypoglycemic and lipid-lowering effects of 4-benzyloxy-5-benzylidene-1,3-thiazolidine-2,4-diones mediated by dual PPAR α/γ modulation.
Madrigal-Angulo JL; Ménez-Guerrero C; Estrada-Soto S; Ramírez-Espinosa JJ; Almanza-Pérez JC; León-Rivera I; Hernández-Núñez E; Aguirre-Vidal Y; Flores-León CD; Aguayo-Ortíz R; Navarrete-Vazquez G
Bioorg Med Chem Lett; 2022 Aug; 70():128804. PubMed ID: 35598791
[TBL] [Abstract][Full Text] [Related]
18. Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids.
Havrylyuk D; Roman O; Lesyk R
Eur J Med Chem; 2016 May; 113():145-66. PubMed ID: 26922234
[TBL] [Abstract][Full Text] [Related]
19. An Insight into the Synthesis and SAR of 2,4-Thiazolidinediones (2,4-TZD) as Multifunctional Scaffold: A Review.
Sethi NS; Prasad DN; Singh RK
Mini Rev Med Chem; 2020; 20(4):308-330. PubMed ID: 31660809
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA
Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
